My latest article on $CRSP @CRISPRTX Also my 101st for Seeking Alpha. Thanks to all my readers! Read why I am maintaining my buy rating, despite slow Casgevy roll-out. https://t.co/3R2fdanU0I
Curious about Tempus AI @TempusAI ? Read my take on it here. I believe it could become a health technology powerhouse, advancing data-driven precision medicine into the new age: https://t.co/1BYB4EYxsc
My latest analysis. This was an interesting one, a comparison of Idexx Labs and Zoetis. @IDEXX@Laboratories@IDEXXwater@Zoetis Thoughts welcome: https://t.co/4mLqlkPbXL
@StockMarketNerd Brad, I think one of the most important skills to develop as an investor is the ability to determine who is worth listening to for advice/guidance/insight and who to avoid. Would you agree?
My latest write-up. This one is on $LENZ Lenz Therapeutics. After a bullish take in my initial coverage, their Q4 results have forced a bearish revaluation: https://t.co/QuDwSMQdVw